{"filing":{"accession_number":"0001104659-26-091266","cik":"0001771706","ticker":"VREOF","company_name":"Vireo Growth Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-07-30","primary_document":"tm2621363d5_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1771706/000110465926091266/tm2621363d5_8k.htm"},"events":[{"id":24216,"run_id":21928,"accession_number":"0001104659-26-091266","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"Vireo Growth Inc. entered into four definitive Securities Purchase Agreements on July 30, 2026, to acquire 100% of the membership interests of four Ohio-based cannabis entities (FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC) for approximately $208 million in subordinate voting shares. The transaction establishes a vertically integrated operating platform in Ohio with eight dispensaries, cultivation, and processing facilities, expected to close in Q4 2026 subject to regulatory approvals.","company_name":"Vireo Growth Inc.","ticker":"VREOF","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":24691,"accession_number":"0001104659-26-091266","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Vireo Growth Inc. entered into four definitive Securities Purchase Agreements on July 30, 2026, to acquire 100% of the membership interests of four Ohio-based cannabis entities (FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, and two others). The aggregate purchase price is approximately $208 million, payable in subordinate voting shares over three tranches. This constitutes a material acquisition transaction under Item 1.01, with significant strategic and financial implications for the registrant's expansion into Ohio and national footprint.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T00:36:00.888863+00:00","company_name":"","ticker":null,"filing_date":""},{"id":24692,"accession_number":"0001104659-26-091266","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Vireo announced entry into four definitive Securities Purchase Agreements to acquire all membership interests of four Ohio cannabis entities (FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC) for approximately $208 million in subordinate voting shares. The transaction establishes a vertically integrated operating platform in Ohio with eight dispensaries, cultivation, and processing facilities, and is expected to close in Q4 2026 subject to regulatory approvals. This constitutes a material acquisition activity under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T00:36:00.888863+00:00","company_name":"","ticker":null,"filing_date":""},{"id":24693,"accession_number":"0001104659-26-091266","item_number":"8.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses entry into four definitive Securities Purchase Agreements to acquire 100% of the membership interests of four Ohio-based cannabis entities (Canoe Hill Ohio, LLC and CAOH LLC are detailed in Item 8.01). The aggregate purchase price is approximately $208 million in subordinate voting shares, representing a material acquisition that will establish Vireo's presence in Ohio with eight dispensaries, cultivation, and processing facilities. This constitutes a material acquisition activity under Item 1.01/2.01 standards, disclosed under Item 8.01 (Other Events).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T00:36:00.888863+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24691,"accession_number":"0001104659-26-091266","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Vireo Growth Inc. entered into four definitive Securities Purchase Agreements on July 30, 2026, to acquire 100% of the membership interests of four Ohio-based cannabis entities (FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, and two others). The aggregate purchase price is approximately $208 million, payable in subordinate voting shares over three tranches. This constitutes a material acquisition transaction under Item 1.01, with significant strategic and financial implications for the registrant's expansion into Ohio and national footprint.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T00:36:00.888863+00:00","company_name":"Vireo Growth Inc.","ticker":"VREOF","filing_date":"2026-08-05"},{"id":24692,"accession_number":"0001104659-26-091266","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Vireo announced entry into four definitive Securities Purchase Agreements to acquire all membership interests of four Ohio cannabis entities (FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC) for approximately $208 million in subordinate voting shares. The transaction establishes a vertically integrated operating platform in Ohio with eight dispensaries, cultivation, and processing facilities, and is expected to close in Q4 2026 subject to regulatory approvals. This constitutes a material acquisition activity under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T00:36:00.888863+00:00","company_name":"Vireo Growth Inc.","ticker":"VREOF","filing_date":"2026-08-05"},{"id":24693,"accession_number":"0001104659-26-091266","item_number":"8.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses entry into four definitive Securities Purchase Agreements to acquire 100% of the membership interests of four Ohio-based cannabis entities (Canoe Hill Ohio, LLC and CAOH LLC are detailed in Item 8.01). The aggregate purchase price is approximately $208 million in subordinate voting shares, representing a material acquisition that will establish Vireo's presence in Ohio with eight dispensaries, cultivation, and processing facilities. This constitutes a material acquisition activity under Item 1.01/2.01 standards, disclosed under Item 8.01 (Other Events).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T00:36:00.888863+00:00","company_name":"Vireo Growth Inc.","ticker":"VREOF","filing_date":"2026-08-05"}]}